Community Dialysis Center in Mentor, Ohio - Dialysis Center

Community Dialysis Center is a medicare approved dialysis facility center in Mentor, Ohio and it has 26 dialysis stations. It is located in Lake county at 8900 Tyler Blvd, Mentor, OH, 44060. You can reach out to the office of Community Dialysis Center at (440) 951-3602. This dialysis clinic is managed and/or owned by Centers For Dialysis Care. Community Dialysis Center has the following ownership type - Non-Profit. It was first certified by medicare in November, 1980. The medicare id for this facility is 362505 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameCommunity Dialysis Center
Location8900 Tyler Blvd, Mentor, Ohio
No. of Dialysis Stations 26
Medicare ID362505
Managed ByCenters For Dialysis Care
Ownership TypeNon-Profit
Late Shifts Yes

Contact Information


8900 Tyler Blvd, Mentor, Ohio, 44060
(440) 951-3602

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Community Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1437246063
Organization NameCenter For Dialysis Care, Mentor
Doing Business AsCommunity Dialysis Center
Address8900 Tyler Blvd Mentor, Ohio, 44060
Phone Number(440) 951-3602

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.57%67%
Patients who reported that nephrologists usually communicated and cared for them.25%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.18%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).60%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).30%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).10%14%

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.65%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.19%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.16%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).69%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).22%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).9%12%

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 85%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.15%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).69%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).21%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).10%12%

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data60
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL5

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center122
    Adult patient months included in Kt/V greater than or equal to 1.2995
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Healthcare providers to incorporate new technologies to improve their business and patient care

    Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

    Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

    Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

    New study identifies 44 genomic variants linked to depression

    A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

    Primary tumor, node location important in stage III NSCLC prognosis

    Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

    Read more Medical News

    › Verified 4 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center1
    Adult patient months included in Kt/V greater than or equal to 1.71
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Healthcare providers to incorporate new technologies to improve their business and patient care

    Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

    Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

    Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

    New study identifies 44 genomic variants linked to depression

    A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

    Primary tumor, node location important in stage III NSCLC prognosis

    Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

    Read more Medical News

    › Verified 4 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Community Dialysis Center with elevated calcium levels.

Patients with hypercalcemia124
Hypercalcemia patient months1013
Hypercalcemia patients with serumcalcium greater than 10.2 mg2
Patients with Serumphosphor130
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL18
Patients with Serumphosphor from 4.6 to 5.5 mg/dL27
Patients with Serumphosphor from 5.6 to 7 mg/dL30
Patients with Serumphosphor greater than 7 mg/dL19

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 93
Patient months included in arterial venous fistula and catheter summaries 700
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment77
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer6

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary100
Hospitalization Rate in facility178.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit301.6
Hospitalization Rate: Lower Confidence Limit114.5

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Community Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility21.3 (As Expected)
Readmission Rate: Upper Confidence Limit29.2
Readmission Rate: Lower Confidence Limit14.6

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Community Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.37 (Better than Expected)
SIR: Upper Confidence Limit1
SIR: Lower Confidence Limit.09

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Community Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 89
Transfusion Rate in facility28.1 (As Expected)
Transfusion Rate: Upper Confidence Limit72.2
Transfusion Rate: Lower Confidence Limit12.3

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Community Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary568
Mortality Rate in facility17.9 (As Expected)
Mortality Rate: Upper Confidence Limit21.9
Mortality Rate: Lower Confidence Limit14.6

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago


Dialysis Facility in Mentor, OH

Community Dialysis Center
Location: 8900 Tyler Blvd, Mentor, Ohio, 44060
Phone: (440) 951-3602
FMC - Mentor Dialysis
Location: 8840 Tyler Blvd, Mentor, Ohio, 44060
Phone: (440) 974-3459
CDC Home Care Mentor
Location: 8900 Tyler Blvd, Mentor, Ohio, 44060
Phone: (440) 951-3602

News Archive

Healthcare providers to incorporate new technologies to improve their business and patient care

Healthcare providers realize that new technologies have to be adopted to improve their business, but the medical benefits of technology also are clearly in their sights, according to CompTIA's Healthcare IT Market: Insights and Opportunities study.

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

New study identifies 44 genomic variants linked to depression

A new meta-analysis of more than 135,000 people with major depression and more than 344,000 controls has identified 44 genomic variants, or loci, that have a statistically significant association with depression.

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

Read more Medical News

› Verified 4 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.